NEW YORK—An advertising industry trade group that monitors advertising claims has recommended that Bausch + Lomb modify or discontinue certain advertising claims about its PeroxiClear Contact Lens Peroxide Solution, including claims of superior comfort over Clear Care, a competing product manufactured by Alcon Laboratories.

However, the group, known as the National Advertising Division (NAD), determined that Bausch + Lomb could support claims that its product “keeps lenses moister for longer.”

NAD opened an inquiry into claims made by Bausch + Lomb following a challenge by Alcon. During the course of NAD’s review, Bausch + Lomb said it had voluntarily and permanently discontinued a number of claims.

Bausch + Lomb said it would comply with NAD’s recommendations. However, the company said, it respectfully disagrees with “NAD’s conclusion that the randomized clinical trial submitted by Bausch + Lomb is insufficient to substantiate the comparative comfort claims at issue.”

NAD is an investigative unit of the advertising industry’s system of self-regulation, which is overseen by The Advertising Self-Regulatory Council and administered by the Council of Better Business Bureaus.